France DNA Sequencing Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Instruments and Consumables), By Technology (Sanger Sequencing and Next-Generation Sequencing), and France DNA Sequencing Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI11985
PAGES 219
REPORT FORMAT PathSoft

France DNA Sequencing Market Insights Forecasts to 2035 

  • The France DNA Sequencing Market Size was Estimated at USD 370.3 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 21.17% from 2025 to 2035
  • The France DNA Sequencing Market Size is Expected to Reach USD 3062.1 Million by 2035

France DNA Sequencing Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights and Consulting, The France DNA Sequencing Market Size is anticipated to reach USD 3062.1 Million by 2035, growing at a CAGR of 21.17% from 2025 to 2035. The market is expanding at a rapid rate and is currently in a high-growth stage.  Rapid technological advancements, like the use of AI and machine learning in genomics, have allowed for a high degree of innovation in the market.

 

Market Overview 

The French DNA sequencing market is a fast-growing industry, driven by government programs, technological developments, and increasing demands for personalized medicine and genomic studies. DNA sequencing is the process of determining the exact sequence of nucleotides in a DNA molecule, encompassing applications for drug development, research, and clinical diagnostics. With further adoption of next-generation and whole-genome sequencing technologies applied to clinical diagnosis, the application of DNA sequencing is identified in a new stratum. This is expected to support growth in the market in the forecast period.  The emergence of sequencing technologies would change genomics and its role in the greater healthcare industry. A significant part of advanced sequencing technologies has to do with sequencing speed. With NGS platforms, including Illumina's, genetic code information has dramatically increased in speed.

 

Report Coverage

This research report categorizes the market for the France DNA sequencing market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France DNA sequencing market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France DNA sequencing market. 

 

France DNA Sequencing Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 370.3 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :CAGR Of 21.17%
2035 Value Projection:USD 3062.1 Million
Historical Data for:2020-2023
No. of Pages:219
Tables, Charts & Figures:99
Segments covered:By Product & Service and By Technology
Companies covered:: Agilent Technology, PacBio, Illumina, Inc., PierianDx, Eurofins Scientific, Bio-Rad Laboratories, Inc., Macrogen, Inc., BGI, PerkinElmer Genomics, and Others
Pitfalls & Challenges:COVID-19 Empact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

Several factors are informing the expansion of the French DNA sequencing market. These include the ongoing advances in technological innovation, the growing number of clinical applications, and government initiatives supporting genomics research in France. In particular, the widespread adoption of Next-Generation Sequencing (NGS), personalized medicine applications, and research & development are accelerating the French DNA sequencing market. The France market growth stage is at high levels, and the market growth is accelerating. The market has a high level of innovation from rapid technological advancements, such as the use of artificial intelligence and machine learning in genomics. Companies are creating new innovative solutions by adopting artificial intelligence, and it is anticipated that this will drive innovation in the industry.

 

Restraining Factors

France has a number of obstacles within the DNA sequencing market, including the cost of sequencing technologies, the analysis of data, and the ethical dilemmas surrounding testing, such as privacy and discrimination. France is heavily investing in genomic medicine, and while these hurdles are being addressed each day, in order for France to adopt and implement DNA sequencing beyond the medical realm, these challenges must be solved.

 

Market Segmentation

The France DNA Sequencing Market share is classified into product & service, and technology.

 

  • The consumables segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France DNA sequencing market is segmented by product & service into instruments and consumables. Among these, the consumables segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. One of the main reasons for increasing market share is the increasing availability of reagents and kits made for different phases of library construction, such as DNA fragmentation, adapter ligation, and quality control. Numerous of these tools are distinguished by their pre-made components, streamlined and simplified workflows, and compatibility with formalin-fixed and low-input specimens.

 

  • The next-generation sequencing segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France DNA sequencing market is segmented by technology into Sanger sequencing, next-generation sequencing. Among these, the next-generation sequencing segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Genome sequencing has become more affordable and accurate due to the drastic advancements in these technologies, as well as the decreasing time and cost of sequencing.  Furthermore, the segment's revenue share is positively impacted by the growing acceptance of NGS technology as a standard clinical diagnostic test, especially in light of the COVID-19 pandemic.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France DNA sequencing market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

 

List of Key Companies

  • Agilent Technology
  • PacBio
  • Illumina, Inc.
  • PierianDx
  • Eurofins Scientific
  • Bio-Rad Laboratories, Inc.
  • Macrogen, Inc.
  • BGI
  • PerkinElmer Genomics
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France DNA Sequencing Market based on the below-mentioned segments:

 

France DNA Sequencing Market, By Product & Service                                               

  • Instruments
  • Consumables 

 

France DNA Sequencing Market, By Technology                                                

  • Sanger Sequencing
  • Next-Generation Sequencing

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies